Thomas G Wiggans Jasper Therapeutics, Inc. (JSPR) insider trading activity

Thomas G Wiggans is Director of Jasper Therapeutics, Inc.. Currently has a direct ownership of 50,000 shares of JSPR, which is worth approximately $1.3 Million. The most recent transaction as insider was on Nov 28, 2023, when has been sold 10,000 shares (Voting Common Stock) at a price of $0.65 per share, resulting in proceeds of $6,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 50K

0% 3M change

n/a 12M change

Total Value Held $1.3 Million

THOMAS G WIGGANS Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 28 2023	BUY Open market or private purchase	$6,500 $0.65 p/Share	10,000 Added 16.67%	50,000 Voting Common Stock
Nov 21 2023	BUY Open market or private purchase	$6,400 $0.64 p/Share	10,000 Added 20.0%	40,000 Voting Common Stock
Nov 20 2023	BUY Open market or private purchase	$6,300 $0.63 p/Share	10,000 Added 25.0%	30,000 Voting Common Stock
Nov 17 2023	BUY Open market or private purchase	$6,000 $0.6 p/Share	10,000 Added 33.33%	20,000 Voting Common Stock
Nov 16 2023	BUY Open market or private purchase	$6,000 $0.6 p/Share	10,000 Added 50.0%	10,000 Voting Common Stock

Also insider at

CBAY

CymaBay Therapeutics, Inc. Healthcare

ANNX

Annexon, Inc. Healthcare

FMTX

Forma Therapeutics Holdings, Inc. Healthcare

Director

PRDS

PARDES BIOSCIENCES, INC. Healthcare

Chief Executive Officer

TGW

Thomas G Wiggans

Director

Carlsbad, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JSPR shares.

Notify only if

Value

Insider Trading

Get notified when an Jasper Therapeutics, Inc. insider buys or sells JSPR shares.

Notify only if

Operation

Value

Type

News

Receive news related to Jasper Therapeutics, Inc.

Track Activities on JSPR

Account